Montpark (montelukast) trial results by Prof Per Svenningsson

[@xcicilyx]

very encouraging

[@jnerses]

Is it possible to get this medication now?

[@nosilverbullet4pd998]

This is an existing anti inflammatory, anti asthma drug but this is a phase 2 trial to see if it can be repurposed for Parkinson’s. It is therefore too early to use it for Parkinson’s, but it is worth keeping an eye on this.